{"id":533,"date":"2024-01-17T21:20:09","date_gmt":"2024-01-17T19:20:09","guid":{"rendered":"https:\/\/demo.artureanec.com\/themes\/neuros\/?page_id=533"},"modified":"2024-01-17T21:20:09","modified_gmt":"2024-01-17T19:20:09","slug":"blog-classic","status":"publish","type":"page","link":"https:\/\/www.tabukpharmaceuticals.com\/ar\/blog-classic\/","title":{"rendered":"Blog Classic"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\n
\n
\n \r\n
\r\n
\r\n
\"althera\"<\/picture><\/a><\/div>
\u0623\u0643\u062a\u0648\u0628\u0631 28, 2025<\/a><\/div>
odeh<\/a><\/div><\/div><\/div><\/div>

Tabuk Pharma and Althera Laboratories Announce Strategic Licensing and Supply Agreement for Advanced Type 2 Diabetes Therapy in MENA<\/a><\/h3>
Tabuk Pharma has entered into a strategic partnership with Althera Laboratories to introduce an innovative treatment for type 2 diabetes across the MENA region. This collaboration reinforces Tabuk Pharma\u2019s commitment<\/div>
\u0627\u0644\u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u0635\u062d\u0641\u064a\u0629<\/a><\/div><\/div> <\/div>\r\n<\/div>\r\n
\r\n
\r\n
\"globalhealth\"<\/picture><\/a><\/div>
\u0623\u0643\u062a\u0648\u0628\u0631 1, 2025<\/a><\/div>
odeh<\/a><\/div><\/div><\/div><\/div>

Tabuk Pharma Signs Strategic Agreements with Local Content and Government Procurement Authority at Global Health Exhibition 2025<\/a><\/h3>
As part of the Global Health Exhibition 2025, Tabuk Pharma signed two strategic agreements with the Local Content and Government Procurement Authority, marking a significant milestone in strengthening pharmaceutical lo<\/div>
\u0627\u0644\u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u0635\u062d\u0641\u064a\u0629<\/a><\/div><\/div> <\/div>\r\n<\/div>\r\n
\r\n
\r\n
\"hanmi\"<\/picture><\/a><\/div>
\u0633\u0628\u062a\u0645\u0628\u0631 8, 2025<\/a><\/div>
odeh<\/a><\/div><\/div><\/div><\/div>

Tabuk Pharma Signs Exclusive License and Supply Agreement with Hanmi Pharmaceutical for Rolontis\u00ae (Eflapegrastim) in Saudi Arabia and MENA<\/a><\/h3>
Tabuk Pharma and Hanmi Pharmaceutical have signed an exclusive license and supply agreement for Rolontis\u00ae (Eflapegrastim), an innovative biologic for the treatment of chemotherapy-induced neutropenia, across Saudi Ara<\/div>
\u0627\u0644\u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u0635\u062d\u0641\u064a\u0629<\/a><\/div><\/div> <\/div>\r\n<\/div>\r\n
\r\n
\r\n
\"image1\"<\/picture><\/a><\/div>
\u064a\u0648\u0646\u064a\u0648 10, 2025<\/a><\/div>
Ilyes Haddad<\/a><\/div><\/div><\/div><\/div>

\u0623\u0639\u0644\u0646\u062a \u0634\u0631\u0643\u0629 \u062a\u0628\u0648\u0643 \u0644\u0644\u0623\u062f\u0648\u064a\u0629 \u0639\u0646 \u0634\u0631\u0627\u0643\u0629 \u062d\u0635\u0631\u064a\u0629 \u0645\u0639 \u0634\u0631\u0643\u0629 \u0628\u0648\u0644\u0627\u0631\u064a\u0633 \u0644\u0644\u0623\u062f\u0648\u064a\u0629 \u0644\u062a\u0642\u062f\u064a\u0645 ADI-PEG20\u060c \u0648\u0647\u0648 \u0645\u0646\u0635\u0629 \u0645\u0628\u062a\u0643\u0631\u0629 \u0644\u062a\u062d\u0644\u0644 \u0627\u0644\u0623\u0631\u062c\u064a\u0646\u064a\u0646 \u0645\u0646 \u0627\u0644\u062f\u0631\u062c\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0644\u0639\u0644\u0627\u062c \u0623\u0646\u0648\u0627\u0639 \u0627\u0644\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062a\u064a \u064a\u0635\u0639\u0628 \u0639\u0644\u0627\u062c\u0647\u0627 \u0641\u064a \u0627\u0644\u0645\u0645\u0644\u0643\u0629 \u0627\u0644\u0639\u0631\u0628\u064a\u0629 \u0627\u0644\u0633\u0639\u0648\u062f\u064a\u0629 \u0648\u0645\u0646\u0637\u0642\u0629 \u062f\u0648\u0644 \u0645\u062c\u0644\u0633 \u0627\u0644\u062a\u0639\u0627\u0648\u0646 \u0627\u0644\u062e\u0644\u064a\u062c\u064a.<\/a><\/h3>
Strategic Collaboration to Address Critical Healthcare Needs and Expand Access to Life-Changing Treatments Riyadh \u2013 Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a l<\/div>
\u0627\u0644\u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u0635\u062d\u0641\u064a\u0629<\/a><\/div><\/div> <\/div>\r\n<\/div> <\/div>\n\n